Chemtros Co., Ltd. Overview
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Employees (headcount) | — | — | 176 |
*Note: Morningstar reports 143 and 151 employees at undated snapshots.
Chemtros is a Korean small-cap fine-chemicals manufacturer built on organic synthesis, high-purity purification and, since April 2024, anionic polymerisation. The company is in the middle of a business-model shift. Historically it lived on lithium-ion battery electrolyte additives, industrial and electronic adhesives, display intermediates and pharmaceutical intermediates/APIs. It is now becoming a localised supplier of semiconductor photoresist (PR) materials: KrF polymers, photo-acid generators (PAG), monomers, photosensitive compounds and, increasingly, EUV-generation materials. These are sold mainly to Korean PR formulators and flow through to Samsung Electronics and SK hynix. Semiconductor materials rose from about 10% of sales in 2023 to about 51% in 1H2026, which lifted gross and operating margins to record levels. Chemtros is a second-tier supplier with KRW 57 bn in FY2025 revenue (LTM to June 2026: about KRW 71 bn). Its customers are far larger than it is, its balance sheet has only just been repaired, and its case rests on Korea's push for materials self-sufficiency and on AI-driven HBM and advanced-logic demand.
What the company does
Chemtros develops, synthesises, purifies and sells speciality chemical materials to industrial customers. Its activities fall into five product families: (1) semiconductor process materials, chiefly photoresist raw materials (polymers, PAGs, monomers and photosensitive compounds), plus wafer-process materials and cleaning thinners; (2) secondary-battery electrolyte additives (the company's CTW, CTL and CTH series, including a thermal-runaway / fire-prevention additive); (3) display materials and functional intermediates for OLED and LCD; (4) pharmaceutical intermediates and active pharmaceutical ingredients (APIs); and (5) polymer adhesive and sealant materials. The last family covers epoxy adhesives for camera modules and LED TVs, die-attach adhesives, silicone conformal-coating sealants, modified silicone sealants, speaker adhesives and heat-dissipating underfill adhesives (Hankyung, 2025-06-01; Simply Wall St company description; Daum/interview, 2026-06-24). The company also trades merchandise. Craft lists formic acid and xylenes among its products, and merchandise was 18% of 2022 revenue (Hana Securities via Smart Today, 2023-03-29).
The company's own recent description, in press releases accompanying its 1H2026 results (13 August 2026), presents Chemtros as an "advanced chemical materials" specialist. It says its semiconductor business centres on PR process materials for the lithography step, built on proprietary synthesis and high-purity purification, and that it has recently extended the line-up to EUV process materials. Management describes semiconductor materials and battery materials as its "two main growth pillars" (Asia Economy and Edaily, 2026-08-13; CEO interview, 2026-06-24).
Business model and revenue model
Chemtros is a pure product business. Revenue comes from B2B sales of manufactured chemicals priced per kilogram or per ton under customer qualification. No service, subscription or licensing revenue was found in any source. The one exception is ODM (original design manufacturing) solutions, which StockHub lists as an activity but which appear to be adhesive formulation work for customers rather than a separate service line; revenue share not publicly disclosed. The model has three economic features:
-
Consumable, utilisation-linked demand. Chemtros' materials are consumed in customers' production. Sales therefore track customers' fab and cell-plant utilisation rather than capital spending cycles (ETFShopping company summary). That means volatility when Korean battery cell production stalls, as it did in 2023–2025, and leverage when semiconductor utilisation is high, as in 2026.
-
Qualification lock-in. Once a material is designed into a customer's PR formulation or electrolyte recipe, switching suppliers requires requalification. Third-party estimates put this at 2–3 years for battery additives (KoalaGains analysis, 2025-11-28). That creates stickiness but also long sales cycles.
-
Tiered supply chain position. Chemtros generally sells to intermediate formulators: PR makers such as Dongjin Semichem and Samsung SDI's electronic materials business, and electrolyte makers. Those formulators in turn supply the end chipmakers (Samsung Electronics, SK hynix) and cell makers (LG Energy Solution, Samsung SDI, SK On) (Hankyung, 2025-06-01; Hana Securities via Smart Today, 2023-03-29).
Value-chain position
In semiconductors, Chemtros sits upstream of PR formulators. It makes the polymer resin, PAG and monomer components that the formulator blends into the finished resist. Japanese companies have historically dominated that layer, which is why the business is framed domestically as "materials localisation". In batteries, it is upstream of electrolyte makers, supplying functional additives. In pharmaceuticals, it supplies intermediates and APIs to Korean drug manufacturers. In adhesives, it sells formulated products directly to electronics module makers.
Customer types and named customers
| End-market | Named customers / channel | Source |
|---|---|---|
| Semiconductor materials | Dongjin Semichem, Samsung SDI and others (five domestic and overseas customers); end users Samsung Electronics and SK hynix, with Chemtros as a second-tier supplier | Hankyung, 2025-06-01 |
| Battery electrolyte additives | Supplied via electrolyte makers to Korea's three major cell makers; SK On and Samsung SDI named | Hana Securities via Smart Today, 2023-03-29; Hankyung, 2025-06-01; Financial News, 2024-02-14 |
| Pharmaceuticals (reported) | Daewon Pharmaceutical, Yuhan, Hanmi Pharmaceutical | Hankyung, 2025-06-01 |
| Adhesives | Camera module and LED TV makers (unnamed) | Morningstar description |
Customer concentration percentages are not publicly disclosed in sources reviewed. Independent analysis characterises concentration as high (KoalaGains, 2025-11-28).
End-markets served
Semiconductors (lithography materials for DRAM, HBM and advanced logic), lithium-ion batteries (EV, IT devices and, increasingly, energy storage systems for AI data centres), displays (OLED/LCD), pharmaceuticals, and electronics assembly (camera modules, TVs, speakers). Under research: water-electrolysis materials and vanadium redox flow batteries (CEO interview, 2026-06-24).
Independent characterisation
Chemtros is best understood as a technology-led contract-style synthesis house in transition to a niche semiconductor-materials specialist. Its competitive asset is process know-how: scaling multi-step organic syntheses and polymerisations from gram-scale laboratory work to tens-of-tons production at the purity the semiconductor industry needs. The CEO himself calls this "completely different technology" from laboratory synthesis (interview, 2026-06-24). Its weaknesses are sub-scale size, dependence on a few domestic formulators who are also potential competitors, a history of missing growth forecasts, and, until January 2026, a stretched balance sheet. The 2024–2026 semiconductor ramp is the first time the company has shown operating leverage at scale. Whether that holds depends on retaining design-ins as customers move to EUV and on Korea's continued policy preference for domestic suppliers.
Strategy
Stated strategy themes
Management's recent statements (press releases of 14 May 2026 and 13 August 2026; CEO interview of 24 June 2026; Hankyung feature of 1 June 2025) set out the following themes, paraphrased:
-
Semiconductor-materials localisation as a survival imperative. The CEO frames domestic production of PR materials as essential for Korea's supply-chain security and calls domestic polymer production "insurance" against future supply crises (interview, 2026-06-24).
-
Two growth pillars. Semiconductor materials and battery materials are positioned as joint drivers. The company expects semiconductor materials to exceed 50% of annual revenue if shipments keep growing (Hankyung, 2026-05-14).
-
Move up the technology curve. Extension from KrF materials into EUV process materials and ultra-high-purity EUV materials, tied to AI-driven demand for HBM and advanced system semiconductors (Edaily, 2026-08-13; interview, 2026-06-24).
-
ESS as a new demand axis for electrolyte additives. Energy storage demand from AI data-centre build-outs is presented as a new growth channel for the battery business (interview, 2026-06-24).
-
High-value-added portfolio diversification. Management says it will broaden the high-value-added product portfolio led by semiconductor materials while strengthening existing core businesses such as lithium-ion battery additives (Edaily, 2026-08-13).
-
Capacity ahead of demand. Semiconductor capacity has been built for 2027 demand, with additional investment under review (interview, 2026-06-24).
Strategic initiatives in the last 24 months
| Initiative | Timing | Detail | Source |
|---|---|---|---|
| Jincheon semiconductor-materials expansion (phase 1) | Completed Oct 2025 | Adds PAG, monomer and KrF polymer production; capacity of 2,400 t/year planned by 2028 | Hankyung, 2025-06-01; interview, 2026-06-24 |
| Wafer-process-material capacity expansion | 2,025 | Revenue contribution from 2026 | Hankyung, 2026-05-14 |
| EUV process-material line-up | 2,026 | Portfolio extended into EUV materials | Edaily, 2026-08-13 |
| Balance-sheet recapitalisation via BW conversion | Jan 2026 | Converts bond liabilities to equity; net cash position by 1H2026 | Hankyung, 2026-05-14; ValueLine |
| Next-generation R&D | Ongoing | Water-electrolysis materials, VRFB, ultra-high-purity EUV | Interview, 2026-06-24 |
| Bonus share issue (무상증자) | Under mid- to long-term review (as of mid-2025) | Shareholder-return / liquidity measure; no decision found | Hankyung, 2025-06-01 |
No formal cost-reduction programme, sustainability target or investor day was identified.
Medium-term targets and guidance
| Target | Value | Horizon | Source | Status / comment |
|---|---|---|---|---|
| Revenue | KRW 150 bn | 2,028 | CEO, Hankyung 2025-06-01 | The article ties this to "semiconductor materials expansion"; it is unclear whether KRW 150 bn is total company revenue or the semiconductor segment. Because semiconductor capacity is stated as up to KRW 90 bn, the KRW 150 bn figure is most plausibly total company revenue (analyst interpretation). |
| Operating income | KRW 30 bn | 2,028 | CEO, Hankyung 2025-06-01 | Implies a 20% operating margin vs 10.5% LTM |
| Semiconductor-materials capacity | 2,400 t/year, up to KRW 90 bn revenue | 2,028 | CEO, Hankyung 2025-06-01 | Phase 1 complete |
| Market capitalisation aspiration | KRW 700 bn | Not dated | Hankyung, 2025-06-01 | About 4.7x current market cap |
| FY2025 growth | Revenue and OP up more than 20%; semiconductor revenue up more than 4x | FY2025 | Hankyung, 2025-06-01 | Revenue +12.9% and OP -72.3% (missed); semiconductor revenue up about 3.3x |
| Semiconductor share of revenue | More than 50% | FY2026 | Hankyung, 2026-05-14 | 1H2026: about 51% (on track) |
| 2H2026 | Continued strong performance on semiconductor sales and stable cost ratios | 2H2026 | Edaily, 2026-08-13 | Qualitative |
Products & Services
Chemtros does not publish list prices. Pricing is negotiated B2B per unit weight (pricing model not publicly disclosed beyond this). Launch years are given where a source states them.
Advanced Materials Division — Semiconductor materials
| Product | Description / capability | Target customer | Year / status | Source |
|---|---|---|---|---|
| Photoresist polymers (KrF) | Polymer resins for KrF (248 nm) photoresists, made by anionic polymerisation, which gives tight molecular-weight distribution and purity | PR formulators (Dongjin Semichem, Samsung SDI electronic materials) → Samsung Electronics, SK hynix | First mass production Apr 2024; expanded at Jincheon (phase 1 complete Oct 2025) | Hankyung, 2025-06-01; KIRS 2024-09-05; CEO interview 2026-06-24 |
| Photo-acid generators (PAG) | Light-sensitive acid generators in chemically amplified resists | PR formulators | Added to Jincheon line-up with the new plant | KIRS 2024-09-05; Hankyung 2025-06-01 |
| PR monomers | Monomers for resist polymer synthesis | PR formulators | Added with the new Jincheon plant | KIRS 2024-09-05 |
| Photosensitive materials (감광성 소재) | Photosensitive compounds; the established product before the PAG/monomer/KrF polymer expansion | PR formulators | In production before 2024 | KIRS 2024-09-05 |
| EUV process materials | Ultra-high-purity materials for EUV lithography (product names not disclosed) | Advanced-node PR formulators | Line-up extended recently (2026); ultra-high-purity EUV materials still under R&D | Edaily, 2026-08-13; CEO interview, 2026-06-24 |
| Wafer-process materials | Materials consumed in wafer processing, scaling with wafer volume | Chipmakers / suppliers | Capacity expanded 2025; meaningful contribution expected from 2026 | Hankyung, 2026-05-14 |
| Cleaning thinner | Solvent-based thinner for semiconductor processing | Chipmakers / formulators | In portfolio | CEO interview, 2026-06-24 |
| Zirconium precursor | Zirconium-based thin-film precursor used in 10 nm-class DRAM | DRAM makers / precursor suppliers | Mass production reported 2019; current status not disclosed | Asia Economy, 2019-04-23 |
Advanced Materials Division — Battery materials
| Product | Description / capability | Target customer | Year / status | Source |
|---|---|---|---|---|
| CTW-series electrolyte additive | Electrolyte additive (series designation; specific function not disclosed) | Electrolyte makers → LGES, Samsung SDI, SK On | Current | Hankyung, 2025-06-01 |
| CTL-series electrolyte additive | Electrolyte additive; series designation | As above | Current | Hankyung, 2025-06-01 |
| CTH-series electrolyte additive | Electrolyte additive; series designation | As above | Current | Hankyung, 2025-06-01 |
| Thermal-runaway / fire-prevention additive | Additive to suppress thermal runaway | Cell makers via electrolyte makers | Current / development stage not specified | Hankyung, 2025-06-01 |
| High-temperature and cycle-life additives | Additives improving high-temperature performance and cycle life; positioned for LFP batteries | Korea's big-three cell makers | Current | Smart Today, 2023-03-29; Financial News, 2024-02-14 |
| Localised Japanese-monopoly additive | A battery material previously monopolised by Japanese suppliers, now produced domestically (name not disclosed) | Cell makers | Localised by 2022 | Financial News, 2022-09-28 |
| PVDF (polyvinylidene fluoride) | Cathode binder; technology transferred from the Korea Research Institute of Chemical Technology; Korea's only domestic PVDF pilot mass-production facility, per Hana Securities | Cathode / cell makers | Pilot scale (2024); commercial scale not confirmed | Financial News, 2024-02-14 |
| Ethylene carbonate / CO₂-to-EC | Technology to capture CO₂ and convert it to ethylene carbonate (an electrolyte solvent) | Electrolyte makers | Development (2022); status not disclosed | Financial News, 2022-09-28 |
Advanced Materials Division — Display, intermediates and pharmaceuticals
| Product | Description | Target customer | Status | Source |
|---|---|---|---|---|
| OLED materials | Materials for OLED displays (specific compounds not disclosed) | Display material makers | Current | Simply Wall St description |
| LCD materials | Materials for LCD displays | Display material makers | Current | Simply Wall St description |
| Functional / compound intermediates | Custom synthesised intermediates for industrial uses | Chemical customers | Current | Jobploy company profile |
| Pharmaceutical intermediates | Intermediates for drug synthesis | Korean pharma (reported: Daewon, Yuhan, Hanmi) | Current; 6% of FY2022 revenue | Hankyung, 2025-06-01; Smart Today, 2023-03-29 |
| APIs | Active pharmaceutical ingredients; one Korean Drug Master File registration is listed under Chemtros (substance not attributable from the source) | Korean pharma | Current | PharmaCompass |
| Merchandise | Traded chemicals; Craft lists formic acid and xylenes | Industrial customers | 18% of FY2022 revenue | Smart Today, 2023-03-29; Craft |
Convergence Materials Division — Polymer adhesives
| Product | Description / capability | Target customer | Status | Source |
|---|---|---|---|---|
| Epoxy adhesive for camera modules | Qualified epoxy for smartphone camera-module assembly | Camera-module makers | Current | Morningstar; Simply Wall St |
| Epoxy adhesive for LED TVs | Epoxy for LED backlight / TV assembly | TV and LED makers | Current | Morningstar |
| Die-attach adhesive | Die bonding | Semiconductor / LED packaging | Current | Simply Wall St |
| Silicone conformal-coating sealants | Protective coating for circuit boards | Electronics makers | Current | Morningstar |
| Modified silicone sealants | Modified-silicone sealant | Industrial / construction | Current | Simply Wall St |
| Speaker adhesives | Adhesives for speaker assembly | Acoustic component makers | Current | Hankyung, 2025-06-01 |
| Heat-dissipating underfill adhesive | Underfill with thermal-dissipation function | Electronics / semiconductor packaging | Technology held (2026) | CEO interview, 2026-06-24 |
| ODM solutions | Customer-specific formulation and production | Electronics / industrial customers | Listed activity | StockHub |
Pipeline / next-generation
| Programme | Description | Status | Source |
|---|---|---|---|
| Ultra-high-purity EUV materials | Next-generation EUV resist components | R&D | CEO interview, 2026-06-24 |
| Water-electrolysis materials | Materials for hydrogen electrolysers | R&D | CEO interview, 2026-06-24 |
| Vanadium redox flow battery (VRFB) materials | Materials for long-duration storage | R&D | CEO interview, 2026-06-24 |
| ESS-oriented electrolyte additives | Additives for energy-storage batteries serving AI data centres | Commercial focus | CEO interview, 2026-06-24 |
Financial Narrative
Sources: Annual revenue, operating income and net income for FY2021–FY2025 from Butler (DART-derived). FY2025 line-item detail and trailing-twelve-month (LTM) figures from ValueLine Korea (DART-derived, consolidated). Balance sheet from ValueLine Korea. Quarterly data from ETFShopping and Hankyung/Edaily. Basis: consolidated K-IFRS unless noted.
FY2025 income statement detail: notes and sources
Source: ValueLine Korea, LTM column ending 2025-12 (equal to FY2025).
Margins (%)
Revenue CAGR FY2021–FY2025: 4.1% (KRW 48.3 bn → KRW 56.8 bn; calculated). Including FY2020 (KRW 43.5 bn), the five-year CAGR FY2020–FY2025 is 5.5%.
Quarterly trajectory
Sources: ETFShopping (Q4 2024–Q3 2025, Q2 2026); Hankyung 2026-05-14 (Q1 2026). Q4 2025 derived as FY2025 minus 9M2025. 1H2026 sums to revenue KRW 41.35 bn, operating income KRW 5.79 bn and net income KRW 12.33 bn. These agree with the company's reported 1H2026 revenue of KRW 41.3 bn, operating income of KRW 5.8 bn and net income of KRW 12.2 bn (Edaily, 2026-08-13).
LTM to 30 June 2026 (ValueLine): revenue KRW 71.17 bn; gross profit KRW 15.09 bn (21.2%); operating income KRW 7.46 bn (10.5%); net income KRW 2.15 bn.
Balance sheet
Source: ValueLine Korea (balance sheet), retrieved October 2026; total debt, net debt and working capital calculated. FY2021 balance-sheet data not available from the source (not shown). Total debt excludes lease liabilities and derivative liabilities. ValueLine shows the FY2022 non-current bond line under both "corporate bond" and "convertible bond" labels; it is treated as a single KRW 16.23 bn instrument.
Analyst note on FY2025 current liabilities: Of KRW 64.85 bn in current liabilities at end-FY2025, identified borrowings and bonds account for only KRW 22.17 bn. Given the KRW 14.58 bn derivative loss recognised in FY2025 and the January 2026 conversion, the residual very likely includes the warrant/conversion-option derivative liability on the outstanding bonds, plus trade payables. The collapse of total liabilities from KRW 69.48 bn to KRW 27.50 bn in 1H2026, while equity rose from KRW 54.72 bn to KRW 101.03 bn, is consistent with the bonds and their embedded derivative being converted into equity in January 2026 (Hankyung, 2026-05-14).
Cash flow: notes and sources
Source: ValueLine Korea. FY2021–FY2024 cash-flow data were not available from the source. ValueLine does not label whether the June 2026 column is year-to-date or trailing; it is shown as reported. The FY2025 column reconciles with the KRW 23.55 bn fall in cash during FY2025 (0.58 − 15.25 − 8.01 = −22.68, with the balance from other investing items).
Ratios
Calculated from the tables above using average equity and assets. ROIC, interest coverage and the cash conversion cycle are not publicly disclosed and could not be calculated reliably: interest expense is not separated from derivative losses in the available data, and daily payables data are lacking. Third-party snapshots of undated periods: interest coverage 1.41x, debt/EBITDA 3.22x, Piotroski F-score 7/9, Altman Z-score 3.8 (GuruFocus). TheVC independently reports a current ratio of 112.9% (2023) and 67.0% (2025), matching the calculations above. StockHub reports a TTM ROE of -21.64% (as of October 2026, trailing basis).
Commentary on trends, inflections and drivers
Revenue. For five years, Chemtros' top line moved sideways in a KRW 47–57 bn band. FY2022 peaked at KRW 57.0 bn on battery-additive demand during the EV build-out. FY2023 fell 16.7% as Korean cell makers destocked and EV demand slowed. FY2024 recovered only modestly (+5.9%) despite the first semiconductor polymer production. FY2025 grew 12.9% to a record KRW 56.8 bn, but almost all of the growth came from semiconductor materials (about +KRW 14 bn), which offset continued weakness in batteries. The inflection arrived in 2026. Q2 2026 revenue of KRW 24.0 bn was a quarterly record and the first quarter above KRW 20 bn. LTM revenue reached KRW 71.2 bn, about 25% above any prior fiscal year.
Margins. Before 2025, operating margins were stable at about 7–8%, the profile of a diversified fine-chemicals house with low pricing power. FY2025 margins compressed to 1.8%: the Jincheon expansion added depreciation and fixed costs before revenue arrived, 2Q–3Q2025 recorded operating losses, and battery volumes stayed weak. 2026 shows operating leverage. The cost-of-sales ratio fell from about 88% in 1H2025 to about 76% in 1H2026 (company, Edaily 2026-08-13), and the Q2 2026 operating margin reached about 15% (KRW 3.6 bn on KRW 24.0 bn). LTM operating margin of 10.5% is already the highest annualised figure in the data set.
Net income. Reported net income has been dominated by non-cash derivative accounting on the company's equity-linked bonds. FY2025's KRW 11.8 bn loss came almost entirely from a KRW 14.6 bn derivative valuation loss in Q4 2025, when a rising share price increased the fair value of the warrant/conversion liability. Operating income was positive. Conversely, Q1 2026 net income of KRW 8.53 bn far exceeded operating income because derivative gains of about KRW 6.1 bn and an accrued-interest reversal were booked on conversion (Hankyung, 2026-05-14). Investors should value the business on operating income and cash flow, not on reported EPS.
Balance sheet. The balance sheet was the main weakness of FY2023–FY2025. Working capital went negative (KRW -21.4 bn at end-FY2025, current ratio 0.67x) because equity-linked bonds and their derivative liability sat in current liabilities while KRW 15.3 bn of FY2025 capex drained cash from KRW 32.1 bn to KRW 8.6 bn. The January 2026 conversion transformed the position. Equity nearly doubled to KRW 101.0 bn, total debt fell to KRW 9.1 bn, the company moved to a net cash position of KRW 4.7 bn, and the current ratio recovered to 2.1x. The cost was dilution of about 20% (share count from 26.56 M to about 32.07 M).
Cash flow. Cash generation has been weak. FY2025 operating cash flow was only KRW 0.6 bn as inventories (+KRW 2.0 bn) and receivables (+KRW 4.8 bn) absorbed cash. Free cash flow was KRW -14.7 bn. The 2026 data show operating cash flow of KRW 6.3 bn, still not enough to fund capex (KRW 10.9 bn). With further capacity investment under review (CEO interview, 2026-06-24), Chemtros may not be self-funding even at the current run-rate. A return to the equity-linked market cannot be ruled out.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Products | Facility base |
|---|---|---|---|
Advanced Materials Division (첨단소재사업부) | Organic synthesis and polymerisation for electronic, energy and pharma uses | Semiconductor PR materials (polymers, PAG, monomers, photosensitive compounds, EUV materials, wafer-process materials, cleaning thinner); battery electrolyte additives (CTW/CTL/CTH series); OLED/LCD display materials and functional intermediates; pharmaceutical intermediates/APIs; merchandise | Ansan Plant 1; Jincheon Plant 3; Ansan R&D Centre |
Convergence Materials Division (융합소재사업부) | Formulated polymer adhesive materials | Epoxy adhesives (camera modules, LED TV), die attach, conformal-coating silicone sealants, modified silicone sealants, speaker adhesives, heat-dissipating underfill | Ansan Plant 2 (28 Byeolmang-ro 270beon-gil, Danwon-gu, Ansan) |
Revenue by Segment
| Product group (KRW Bn) | FY2023 | FY2024 | FY2025 | 1H2025 | 1H2026 |
|---|---|---|---|---|---|
Semiconductor materials | — | 6.0 | 20.05 | 8.0 | 20.9 |
Advanced materials ex-semiconductor (battery, OLED, pharma) | — | 28.5 | — | — | — |
Convergence materials (adhesives) | — | 15.8 | — | — | — |
Total revenue | 47.5 | 50.3 | 56.8 | 26.9 | 41.3 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment (%)
| Metric (% of revenue) | FY2023 | FY2024 | FY2025 | Q1 2026 | 1H2026 |
|---|---|---|---|---|---|
Semiconductor share — Yuanta Securities | 9.7 | 25.2 | 37.0 | — | — |
Semiconductor share — company / press | — | 11.9 | 35.2 | 48 | 51 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansProduct Group Details
| Product group (% of FY2022 revenue) | FY2022 |
|---|---|
Electrolyte additives | 27 |
Other IT materials | 21 |
Polymer adhesive materials | 28 |
Pharmaceutical materials | 6 |
Merchandise | 18 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 48.3 | 57.0 | 47.5 | 50.3 | 56.8 |
Revenue growth YoY (%) | — | 18.0 | -16.7 | 5.9 | 12.9 |
Gross profit (KRW Bn) | — | — | — | — | 8.69 |
Operating income (KRW Bn) | 3.8 | 4.4 | 3.4 | 3.8 | 1.04 |
EBITDA approx. (OP + depreciation of PP&E, KRW Bn) | — | — | — | — | 4.86 |
Pre-tax income (KRW Bn) | — | — | — | — | -13.16 |
Net income (KRW Bn) | 4.4 | 3.8 | 2.8 | 5.1 | -11.84 |
EPS basic (KRW) | — | — | — | — | -445.8 |
Dividends per share (KRW) | 0 | 0 | 0 | 0 | 0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Analysis
| Line item | FY2025 |
|---|---|
Revenue | 56.81 |
Cost of sales | 48.11 |
Gross profit | 8.69 |
SG&A (incl. R&D) | 7.64 |
— of which R&D | 2.74 |
Operating income | 1.04 |
Finance income | 0.79 |
Finance costs | 14.99 |
— of which derivative valuation loss | 14.58 |
Other non-operating, net | 0.00 |
Pre-tax income | -13.16 |
Income tax (benefit) | -1.32 |
Net income | -11.84 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | — | — | — | — | 15.3 |
Operating margin (%) | 7.9 | 7.7 | 7.2 | 7.6 | 1.8 |
EBITDA margin approx. (%) | — | — | — | — | 8.6 |
Net margin (%) | 9.1 | 6.7 | 5.9 | 10.1 | -20.8 |
Income Statement
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|
Revenue (KRW Bn) | 12.1 | 12.2 | 14.7 | 13.1 | 16.8 | 17.35 | 24.0 |
Operating income (KRW Bn) | 0.5 | 0.2 | -0.9 | -0.6 | 2.34 | 2.19 | 3.6 |
Net income (KRW Bn) | 1.7 | 0.4 | -2.2 | 0.5 | -10.54 | 8.53 | 3.8 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | 1H2026 |
|---|---|---|---|---|---|
Total assets (KRW Bn) | 97.45 | 97.84 | 125.69 | 124.21 | 128.54 |
Current assets (KRW Bn) | 50.70 | 34.94 | 59.71 | 43.43 | 47.86 |
Cash and equivalents (KRW Bn) | 8.44 | 10.05 | 32.13 | 8.58 | 13.86 |
Trade and other receivables (KRW Bn) | 10.88 | 7.96 | 7.06 | 11.85 | 14.25 |
Inventories (KRW Bn) | 12.25 | 14.13 | 15.41 | 17.45 | 19.35 |
Property plant and equipment (KRW Bn) | 44.89 | 58.81 | 61.60 | 74.47 | 74.26 |
Goodwill (KRW Bn) | 0 | 0 | 0 | 0 | 0 |
Intangible assets (KRW Bn) | 0.55 | 0.52 | 0.74 | 0.70 | 1.81 |
Total liabilities (KRW Bn) | 38.50 | 36.16 | 59.04 | 69.48 | 27.50 |
Current liabilities (KRW Bn) | 16.36 | 30.95 | 54.66 | 64.85 | 22.72 |
Short-term borrowings (KRW Bn) | 6.50 | 6.50 | 11.00 | 5.00 | 3.00 |
Current bonds incl. CB/BW (KRW Bn) | 0 | 19.62 | 17.13 | 17.17 | 5.49 |
Long-term borrowings (KRW Bn) | 2.15 | 1.79 | 0.64 | 0.64 | 0.64 |
Non-current bonds incl. CB (KRW Bn) | 16.23 | 0 | 0 | 0 | 0 |
Total debt (borrowings + bonds, KRW Bn) | 24.88 | 27.91 | 28.77 | 22.81 | 9.13 |
Net debt (KRW Bn) | 16.44 | 17.86 | -3.36 | 14.23 | -4.73 |
Total equity (KRW Bn) | 58.95 | 61.68 | 66.65 | 54.72 | 101.03 |
Working capital (KRW Bn) | 34.34 | 3.99 | 5.05 | -21.42 | 25.14 |
Cash Flow
| Metric | FY2025 | LTM or YTD to Jun-2026 |
|---|---|---|
Operating cash flow (KRW Bn) | 0.58 | 6.29 |
Capital expenditure — PP&E additions (KRW Bn) | 15.25 | 10.90 |
Free cash flow (KRW Bn) | -14.67 | -4.61 |
Financing cash flow (KRW Bn) | -8.01 | 2.95 |
Depreciation of PP&E (KRW Bn) | 3.82 | 3.74 |
Dividends paid (KRW Bn) | 0 | 0 |
Share buybacks (KRW Bn) | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2023 | FY2024 | FY2025 | 1H2026 / LTM |
|---|---|---|---|---|
ROE (%) | 4.6 | 7.9 | -19.5 | — |
ROA (%) | 2.9 | 4.6 | -9.5 | — |
Current ratio (x) | 1.13 | 1.09 | 0.67 | 2.11 |
Debt to equity (x) | 0.45 | 0.43 | 0.42 | 0.09 |
Liabilities to equity (x) | 0.59 | 0.89 | 1.27 | 0.27 |
Net debt to EBITDA (x) | — | — | 2.9 | — |
Asset turnover (x) | 0.49 | 0.45 | 0.45 | — |
Revenue by Region
| Region (KRW Bn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Total revenue | 47.5 | 50.3 | 56.8 |
Share Price History
| Date | Price (KRW) | Context | Source |
|---|---|---|---|
2017-10-11 | — | KOSDAQ listing | Hankyung |
2021-09-30 | 19,000 | All-time post-listing high | Hankyung, 2025-06-01 |
2022-09-28 | 9,560 | Intraday; ethylene-carbonate / CO₂ theme | Financial News |
2024-02-14 | 6,950 | Intraday; PVDF / LFP theme | Financial News |
2025-06-01 | 4,435 | 76.7% below the 2021 peak | Hankyung |
2026-05-14 | 5,380 | Intraday, after Q1 2026 results | Hankyung |
2026-09-25 | 3,930 | Close | MyDailyByte |
2026-10-13 | 4,605 | Close; market cap KRW 147.7 bn | StockHub |
2026-10-14 | 4,515 | Close | MyDailyByte |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
52-week high (KRW) | 9,570 | StockHub |
52-week low (KRW) | 2,630 | StockHub |
Current price vs 52-week range | 28th percentile | StockHub |
Change from 2021 peak (%) | -75.8 | Calculated (4,605 vs 19,000) |
Valuation Multiples
| Multiple | Chemtros | Dongjin Semichem | Chunbo | Basis / source |
|---|---|---|---|---|
Market cap (KRW Bn) | 147.7 | 2,064.3 | 419.1 | StockHub; Butler |
P/E (x) | 68.7 | 21.9 | — | Chemtros on LTM-Jun-2026 NI KRW 2.15 bn (calculated; StockHub shows 52.7x, Butler 70.5x at KRW 4,725); Dongjin on FY2025 NI; Chunbo loss-making |
P/B (x) | 1.46 | — | — | 1H2026 equity KRW 101.0 bn (calculated); StockHub 1.24–1.46x |
EV (KRW Bn) | 143.0 | — | — | Market cap + debt KRW 9.13 bn − cash KRW 13.86 bn |
EV/Sales LTM (x) | 2.0 | — | — | LTM revenue KRW 71.2 bn |
EV/EBITDA LTM (x) | 12.8 | — | — | LTM OP KRW 7.46 bn + depreciation KRW 3.74 bn |
EV/EBIT LTM (x) | 19.2 | — | — | LTM OP KRW 7.46 bn |
P/S (x) | 2.1 | 1.7 | 3.1 | Chemtros on LTM; peers on FY2025 revenue |
Capital Markets
| Item | Status | Source |
|---|---|---|
Dividend history | No dividends paid in FY2021–FY2025; none currently | Stockopedia; Butler |
Dividend policy | Not disclosed; focus on growth reinvestment | StockHub |
Buyback authorisations | None; treasury shares 0% | Butler |
Bonus share issue | Under mid- to long-term review (mid-2025); no decision found | Hankyung, 2025-06-01 |
Moody's / S&P / Fitch ratings | Not rated | — |
Capital Instruments
| Instrument | Amount (KRW Bn) | Maturity bucket |
|---|---|---|
Short-term borrowings | 3.00 | Within 1 year |
Current bonds (equity-linked) | 5.49 | Within 1 year |
Long-term borrowings | 0.64 | Beyond 1 year |
Total | 9.13 | — |
Analyst Conclusions
Management guidance
-
Robust performance expected to continue through 2H2026 on strong semiconductor sales and stable cost ratios (Edaily, 2026-08-13).
-
Semiconductor materials expected to exceed 50% of annual revenue in FY2026 (Hankyung, 2026-05-14); 1H2026 was about 51%.
-
2028 ambitions: revenue of KRW 150 bn and operating income of KRW 30 bn; semiconductor capacity of 2,400 t/year (up to KRW 90 bn of revenue) (Hankyung, 2025-06-01).
-
Capacity sized for 2027 demand; additional investment under review (interview, 2026-06-24).
Consensus
None available (no contributing analysts). As a mechanical illustration only, not a forecast: if 2H2026 revenue matches Q2 2026's KRW 24.0 bn run-rate, FY2026 revenue would be about KRW 89 bn (41.3 + 48.0), roughly +57% YoY. This is an analyst arithmetic scenario, not guidance.
Bull case
-
The mix shift is structural, not cyclical. Semiconductor revenue went from about 12% to about 51% of sales in two years, with qualified positions at formulators supplying Samsung and SK hynix and EUV materials now in the portfolio. Each additional point of semiconductor mix carries a higher margin. The cost-of-sales ratio has already fallen 12 points.
-
The balance sheet is clean and capacity is in place. With net cash of KRW 4.7 bn, a current ratio of 2.1x, and Jincheon phase 1 complete, incremental revenue up to the KRW 90 bn semiconductor capacity ceiling should convert to profit with limited new capital. Q2 2026's roughly 15% operating margin points to the 20% margin implied by the 2028 target.
-
Valuation leaves upside if targets are even partly met. EV of about KRW 143 bn is under 2x LTM sales and about 19x LTM EBIT. Hitting half the 2028 operating-profit target (KRW 15 bn) at 12x EV/EBIT would justify about KRW 180 bn EV, before any credit for battery/ESS recovery or PVDF optionality.
Bear case
-
Track record of missed promises. Revenue forecasts of KRW 71 bn for 2023 and more than KRW 100 bn for 2025 compare with actuals of KRW 47.5 bn and KRW 56.8 bn. FY2025 OP guidance of +20% became -72%. The 2028 targets (2.6x revenue, 29x FY2025 OP) deserve a steep discount.
-
Concentration and cycle risk have increased. Half of revenue now depends on a few Korean PR formulators and the memory cycle, while customers are 20x Chemtros' size and could integrate backward or dual-source. A 2027 memory downturn would hit just as the new capacity needs to be filled.
-
Cash generation and dilution. FCF was KRW -14.7 bn in FY2025 and remains negative in 2026, with further capex under review. Past funding came through equity-linked bonds that diluted holders by about 20%, left residual warrants, and moved a private-equity holder to an apparent 32.66%. That holder, which bought at KRW 9,100, may become a source of selling pressure.
Key catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing | What to watch |
|---|---|---|
| Q3 2026 results | Mid-November 2026 | Whether Q2's KRW 24.0 bn revenue and about 15% OP margin hold; semiconductor share |
| FY2026 business report | March 2027 | Full-year semiconductor share above 50%; FCF; segment profit disclosure |
| Additional capacity investment decision | 2026–27 | Size, funding method (cash vs equity-linked) |
| EUV material qualifications | 2026–27 | Named customer wins or volume disclosure |
| Champion Holdings stake | Ongoing | Confirmation of largest-shareholder status; any block sale or board representation |
| Residual warrants | Ongoing | Exercise volumes and further price adjustments |
| Battery / ESS recovery | 2026–27 | Korean cell-maker utilisation; LFP/ESS additive orders |
| Memory and HBM capex cycle | 2,027 | Samsung / SK hynix capex and wafer starts |
| Bonus share issue | Unspecified | Board resolution |
| PVDF commercialisation | Unspecified | Any move beyond pilot scale |
Analyst verdict
Chemtros is at the most important inflection in its twenty-year history. For most of the last decade it was a sub-scale, low-margin fine-chemicals house whose growth narratives (battery additives, PVDF, CO₂ conversion) produced share-price spikes but not earnings. Revenue stayed between KRW 47 bn and KRW 57 bn from FY2021 to FY2025 while the share price fell about 76% from its 2021 peak. What has changed is concrete and measurable. Semiconductor photoresist materials, built on anionic polymerisation that Chemtros scaled in 2024, now generate about half of revenue. Quarterly sales have reached a record KRW 24 bn, the cost-of-sales ratio has fallen twelve points, and the January 2026 bond conversion removed the balance-sheet overhang that produced a misleading KRW 11.8 bn FY2025 net loss.
On LTM figures the equity trades at about 2x sales and about 19x EBIT. That is neither distressed nor demanding for a company whose operating profit is compounding off a low base. But the investment case rests heavily on management's 2028 targets, and this management team has a documented record of over-promising on revenue, capacity and timing. Its positions are tier-2, its customers are giants, its disclosure is thin, and its free cash flow is still negative with more capex under consideration. The apparent rise of a private-equity holder to about 33%, above the founder group, adds governance uncertainty and potential supply of shares.
Verdict: Chemtros is now a credible small-cap play on Korean semiconductor-materials localisation, but it should be treated as speculative and execution-dependent. The thesis will be confirmed or broken over the next three to four quarters by three data points: sustaining quarterly revenue above KRW 20 bn with double-digit operating margins, turning free cash flow positive without new equity-linked issuance, and evidence of EUV-generation design wins. Until then, position sizing should reflect a business still proving that its 2026 inflection is durable rather than another false dawn.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Background | Age | 2025 compensation | Source |
|---|---|---|---|---|---|---|
Dr. Lee Dong-hoon (이동훈) | Founder, CEO (대표이사) and largest individual shareholder | Since founding (Mar 2006) | Began in 1990 as a new-drug researcher in CJ's pharmaceutical division; chemistry PhD from KAIST; about 10 years in Hansol Group's new-drug division; founded Chemtros with about KRW 200 M of personal savings. KOSDAQ Association Senior Vice Chairman (Feb 2024), 14th Chairman (Feb 2025–present) | Born 1963 (about 63) | KRW 510 M (highest disclosed pay in FY2025; split not available) | Hankyung, 2025-06-01; MTN, 2025-02-25; Economist Korea, 2024-02-23; ETFShopping |
Jeon Sang-hyun (전상현) | Executive (related party of the largest shareholder) | — | — | — | — | ETFShopping |
“—” = not publicly disclosed.
Major Shareholders
| Holder | Stake (%) | Basis / date | Source |
|---|---|---|---|
Champion Holdings (챔피온홀딩스), investment vehicle associated with private-equity manager Noh & Partners | 32.66 | — | ETFShopping; Hankyung, 2025-06-01 (identifies the investor) |
Lee Dong-hoon (CEO) | 14.53 | FY2025 business report | ETFShopping; Hankyung |
Jeon Sang-hyun (executive) | 0.89 | FY2025 business report | ETFShopping |
Lee Hye-jun (related party) | 0.07 | FY2025 business report | ETFShopping |
Lee Hye-in (related party) | 0.05 | FY2025 business report | ETFShopping |
Largest shareholder + related parties | 15.54 | FY2025 business report | ETFShopping; Hankyung |
Minority (retail) shareholders | 63.51 (30,046 holders) | End-2025 | ETFShopping |
Foreign ownership | 2.97 | October 2026 | StockHub |
Treasury shares | 0.00 | 2026 | Butler |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Country | Relevance | Revenue (latest verified) |
|---|---|---|---|---|
PR materials / formulation | Dongjin Semichem (005290) | Korea | Leading Korean PR formulator; Chemtros' customer and potential vertical competitor | FY2025 KRW 1,194.1 bn (Butler) |
PR raw materials | JSR | Japan | Global PR and resist-material leader | — |
PR raw materials | Tokyo Ohka Kogyo (TOK) | Japan | Global PR leader | — |
PR raw materials | Shin-Etsu Chemical | Japan | PR and materials major | — |
PAG | Toyo Gosei; San-Apro | Japan | Specialist PAG suppliers | — |
PR polymers / monomers | Maruzen Petrochemical; Osaka Organic Chemical; Mitsubishi Chemical | Japan | KrF/ArF polymers and monomers | — |
PR materials (domestic) | Youngchang Chemical; Miwon Commercial | Korea | Domestic resist-material localisation competitors | — |
Battery additives / fluorine chemicals | Chunbo (278280) | Korea | Closest listed domestic peer in electrolyte additives and electronic materials | FY2025 KRW 133.8 bn (Butler) |
Battery additives / electrolytes | Soulbrain; Dongwha Electrolyte; Enchem | Korea | Electrolyte makers with in-house additive capability (also channel customers) | — |
Battery additives | Tinci; Capchem; HSC New Energy | China | Large-scale Chinese additive and electrolyte producers | — |
PVDF | Kureha; Syensqo (ex-Solvay); Arkema | Japan / Belgium / France | Dominant PVDF suppliers | — |
Electronic adhesives | Henkel; Namics; Shin-Etsu silicones; ThreeBond; Dow | Germany / Japan / US | Global adhesive leaders | — |
Peer Comparison FY2025
| Metric | Chemtros | Dongjin Semichem | Chunbo |
|---|---|---|---|
Revenue FY2025 (KRW Bn) | 56.8 | 1,194.1 | 133.8 |
Revenue growth FY2025 (%) | 12.9 | -15.2 | -7.7 |
Operating income FY2025 (KRW Bn) | 1.04 | 172.4 | 3.7 |
Operating margin FY2025 (%) | 1.8 | 14.4 | 2.8 |
Net income FY2025 (KRW Bn) | -11.84 | 94.1 | -60.0 |
Net margin FY2025 (%) | -20.8 | 7.9 | -44.8 |
R&D intensity FY2025 (%) | 4.8 | — | — |
Market cap (KRW Bn, latest) | 147.7 | 2,064.3 | 419.1 |



